{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:15:00Z","timestamp":1791220500003,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jval.2022.04.003","type":"journal-article","created":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T06:54:42Z","timestamp":1653202482000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids"],"prefix":"10.1016","volume":"26","author":[{"given":"Mimi","family":"Choon-Quinones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kal\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Zelei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Harousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Durie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Keown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivett","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jval.2022.04.003_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jval.2022.04.003_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-018-0155-7","article-title":"Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma \u2014 an IMWG Research Project","volume":"8","author":"Usmani","year":"2018","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Mutiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jval.2022.04.003_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7812\/TPP\/19.064","article-title":"Important considerations for design and implementation of decision aids for shared medical decision making","volume":"24","author":"Koon","year":"2020","journal-title":"Perm J"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41408-021-00432-4","article-title":"Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life","volume":"11","author":"Terpos","year":"2021","journal-title":"Blood Cancer J"},{"issue":"2-3","key":"10.1016\/j.jval.2022.04.003_bib7","first-page":"34","article-title":"Patient, physician and contextual factors are influential in the treatment decision making of older adults newly diagnosed with symptomatic myeloma","volume":"2","author":"Tariman","year":"2014","journal-title":"Cancer Treat Commun"},{"issue":"17","key":"10.1016\/j.jval.2022.04.003_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7748\/cnp.2016.e1341","article-title":"Myeloma patients\u2019 self-reported experiences of care and treatment","volume":"15","author":"Galinsky","year":"2016","journal-title":"Cancer Nurs Pract"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pec.2008.09.025","article-title":"What are the external influences on information exchange and shared decision-making in healthcare consultations: a meta-synthesis of the literature","volume":"75","author":"Edwards","year":"2009","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jval.2022.04.003_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1186\/s12885-021-08527-8","article-title":"The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences","volume":"21","author":"Pritlove","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jval.2022.04.003_bib11","article-title":"Evaluating patients\u2019 preferences for multiple myeloma therapy, a discrete-choice-experiment","volume":"5","author":"M\u00fchlbacher","year":"2008","journal-title":"Psychosoc Med"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10198-010-0218-6","article-title":"Analysis of physicians\u2019 perspectives versus patients\u2019 preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma","volume":"12","author":"M\u00fchlbacher","year":"2011","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1634\/theoncologist.2017-0257","article-title":"Individual trade-offs between possible benefits and risks of cancer treatments: results from a stated preference study with patients with multiple myeloma","volume":"1","author":"Postmus","year":"2018","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s12885-020-07018-6","article-title":"Alignment of preferences in the treatment of multiple myeloma \u2014 a discrete choice experiment of patient, carer, physician, and nurse preferences","volume":"20","author":"Fifer","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jval.2022.04.003_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2147\/PPA.S259612","article-title":"Myeloma patient value mapping: a discrete choice experiment on myeloma treatment preferences in the UK","volume":"14","author":"Fifer","year":"2020","journal-title":"Patient Preference Adherence"},{"issue":"suppl","key":"10.1016\/j.jval.2022.04.003_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1188\/13.CJON.S2.25-32","article-title":"Caregivers of multiple myeloma survivors","volume":"17","author":"Kurtin","year":"2013","journal-title":"Clin J Oncol Nurs"},{"issue":"14","key":"10.1016\/j.jval.2022.04.003_bib19","first-page":"1228","article-title":"Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline","volume":"37","author":"Mikhael","year":"2019","journal-title":"Oncology"},{"key":"10.1016\/j.jval.2022.04.003_bib20","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jval.2022.04.003_bib21","first-page":"373","article-title":"Multiple myeloma: diagnosis and treatment","volume":"95","author":"Michels","year":"2017","journal-title":"Am Fam Phys"},{"issue":"12","key":"10.1016\/j.jval.2022.04.003_bib22","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.bbmt.2015.09.016","volume":"21","author":"Giralt","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jval.2022.04.003_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.clml.2020.03.017","article-title":"Clinical updates regarding multiple myeloma from the 2019 American Society of Hematology Annual Meeting","volume":"20","author":"Terpos","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"10.1016\/j.jval.2022.04.003_bib24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1080\/10428194.2018.1427858","article-title":"Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop","volume":"59","author":"Tan","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/imj.12640","volume":"45","author":"Quach","year":"2015","journal-title":"Int Med J"},{"issue":"6","key":"10.1016\/j.jval.2022.04.003_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bjh.14514","article-title":"UK Myeloma Forum (UKMF) and the British Society for Haematology (BSH). Guidelines for screening and management of late and long-term consequences of myeloma and its treatment","volume":"176","author":"Snowden","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","article-title":"Guidelines for supportive care in multiple myeloma 2011","volume":"154","author":"Snowden","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Guidelines for the diagnosis and management of multiple myeloma 2011","volume":"154","author":"Bird","year":"2011","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib29","first-page":"35","article-title":"Guidelines on the diagnosis and management of multiple myeloma treatment","volume":"3","author":"Hungria","year":"2013","journal-title":"Br Med Assoc"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib30","doi-asserted-by":"crossref","first-page":"pzaa180","DOI":"10.1093\/ptj\/pzaa180","article-title":"Mobilization and exercise intervention for patients with multiple myeloma: clinical practice guidelines endorsed by the Canadian Physiotherapy Association","volume":"101","author":"Jeevanantham","year":"2021","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clon.2013.11.022","article-title":"Bortezomib in multiple myeloma: a practice guideline","volume":"26","author":"Kouroukis","year":"2014","journal-title":"Clin Oncol"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3747\/co.20.1252","article-title":"Lenalidomide in multiple myeloma\u2014a practice guideline","volume":"20","author":"Chen","year":"2013","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/os.12267","article-title":"Consensus on surgical management of myeloma bone disease","volume":"8","year":"2016","journal-title":"Orthop Surg"},{"issue":"12","key":"10.1016\/j.jval.2022.04.003_bib35","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3324\/haematol.2019.224204","article-title":"Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from the European Myeloma Network","volume":"104","author":"Moreau","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.jval.2022.04.003_bib36","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European Myeloma Network guidelines for the management of multiple myeloma-related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jval.2022.04.003_bib37","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s41375-018-0142-9","article-title":"Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network","volume":"32","author":"Larocca","year":"2018","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.jval.2022.04.003_bib38","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2011-11-374249","article-title":"Consensus on maintenance therapy in multiple myeloma","volume":"119","author":"Ludwig","year":"2012","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jval.2022.04.003_bib39","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","article-title":"International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib40","first-page":"119","article-title":"International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease","volume":"22","author":"Terpos","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jval.2022.04.003_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-020-00366-3","article-title":"International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)","volume":"10","author":"Mateos","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jval.2022.04.003_bib42","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/leu.2015.356","article-title":"Management of relapsed multiple myeloma: recommendations of the IMWG","volume":"30","author":"Laubach","year":"2015","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.jval.2022.04.003_bib43","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12288-016-0773-9","article-title":"Consensus in the management of multiple myeloma in India at Myeloma State of the Art 2016 Conference","volume":"33","author":"Yanamandra","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"6","key":"10.1016\/j.jval.2022.04.003_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00277-012-1445-y","article-title":"SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma","volume":"91","author":"Barosi","year":"2012","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib51","first-page":"353","article-title":"Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a mSMART consensus statement","volume":"54","author":"Gonsalves","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jval.2022.04.003_bib52","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","article-title":"Multiple myeloma, version 3.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"8","author":"Kumar","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.11622\/smedj.2016150","article-title":"Consensus Guidelines for the management of patients with multiple myeloma","volume":"58","author":"de Mel","year":"2017","journal-title":"Singapore Med J"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib55","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma","volume":"8","author":"Shah","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ijlh.12097","article-title":"United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma","volume":"36","author":"Pratt","year":"2014","journal-title":"Int J Lab Hematol"},{"issue":"8","key":"10.1016\/j.jval.2022.04.003_bib57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00277-010-0925-1","article-title":"Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma","volume":"89","author":"Palumbo","year":"2010","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.jval.2022.04.003_bib58","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3109\/10428194.2010.487959","article-title":"Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches","volume":"51","author":"Engelhardt","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jval.2022.04.003_bib59","doi-asserted-by":"crossref","first-page":"w14100","DOI":"10.4414\/smw.2015.14100","article-title":"Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland","volume":"145","author":"Samaras","year":"2015","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib60","article-title":"Development of an initial conceptual model of multiple myeloma to support clinical and health economics decision making","volume":"4","author":"Gonzalez-McQuire","year":"2019","journal-title":"MDM Policy Pract"},{"issue":"5","key":"10.1016\/j.jval.2022.04.003_bib61","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1634\/theoncologist.2011-0391","article-title":"European perspective on multiple myeloma treatment strategies: update following recent congresses [published correction in Oncologist. 2012;17(7):1005]","volume":"17","author":"Ludwig","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jval.2022.04.003_bib62","first-page":"1071","article-title":"Gene signature combinations improve prognostic stratification of multiple myeloma patients","volume":"30","author":"Chng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jval.2022.04.003_bib63","author":"Mohty"},{"key":"10.1016\/j.jval.2022.04.003_bib64","doi-asserted-by":"crossref","first-page":"w13054","DOI":"10.4414\/smw.2010.13054","article-title":"Integrating novel agents into multiple myeloma treatment \u2014 current status in Switzerland and treatment recommendations","volume":"140","author":"Taverna","year":"2010","journal-title":"Swiss Med Wkly"},{"issue":"8","key":"10.1016\/j.jval.2022.04.003_bib65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jgo.2020.06.002","article-title":"Management of older and frail patients with multiple myeloma in the Portuguese routine clinical practice: deliberations and recommendations from an expert panel of hematologists","volume":"11","author":"Jo\u00e3o","year":"2020","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40487-019-00100-5","article-title":"Methodology of a novel risk stratification algorithm for patients with multiple myeloma in the relapsed setting","volume":"7","author":"Bouwmeester","year":"2019","journal-title":"Oncol Ther"},{"issue":"8","key":"10.1016\/j.jval.2022.04.003_bib67","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ajh.25117","article-title":"Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management","volume":"93","author":"Rajkumar","year":"2018","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/bjh.12926","article-title":"Updates to the guidelines for the diagnosis and management of multiple myeloma","volume":"167","author":"Pratt","year":"2014","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.jval.2022.04.003_bib75","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.12968\/bjon.2016.25.S18","article-title":"Multiple myeloma: managing a complex blood cancer","volume":"25","author":"Dowling","year":"2016","journal-title":"Br J Nurs"},{"issue":"6","key":"10.1016\/j.jval.2022.04.003_bib87","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1188\/17.CJON.660-664","article-title":"Decision aids: assisting patients with multiple myeloma and caregivers with treatment decision making","volume":"21","author":"Kojovic","year":"2017","journal-title":"CJON"},{"key":"10.1016\/j.jval.2022.04.003_bib88","first-page":"293","article-title":"Decision making in oncology: a review of patient decision aids to support patient participation","volume":"5","author":"Stacey","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jval.2022.04.003_bib89","first-page":"45","article-title":"Decision aids to help older people make health decisions: a systematic review and meta-analysis","volume":"16","author":"van Weert","year":"2016","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.jval.2022.04.003_bib90","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/jamainternmed.2019.0763","article-title":"Decision aids for prostate cancer screening choice: a systematic review and meta-analysis","volume":"179","author":"Riikonen","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.jval.2022.04.003_bib91","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/AOG.0000000000003664","article-title":"Patient decision aids to facilitate shared decision making in obstetrics and gynecology: a systematic review and meta-analysis","volume":"135","author":"Poprzeczny","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jval.2022.04.003_bib92","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s13340-020-00429-7","article-title":"Patient decision aids in clinical practice for people with diabetes: a scoping review","volume":"11","author":"Cornelius","year":"2020","journal-title":"Diabetol Int"},{"key":"10.1016\/j.jval.2022.04.003_bib93","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jss.2018.09.017","article-title":"A\u00a0review of decision aids for patients considering more than one type of invasive treatment","volume":"235","author":"Leinweber","year":"2019","journal-title":"J\u00a0Surg Res"},{"issue":"3","key":"10.1016\/j.jval.2022.04.003_bib94","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MNH.0000000000000321","article-title":"Hard choices, better outcomes: a review of shared decision-making and patient decision aids around dialysis initiation and conservative kidney management","volume":"26","author":"Davis","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152200198X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152200198X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:31:28Z","timestamp":1761096688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830152200198X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S109830152200198X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2022.04.003","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2022.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}